BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10606226)

  • 1. Endothelial progenitor cells as putative targets for angiostatin.
    Ito H; Rovira II; Bloom ML; Takeda K; Ferrans VJ; Quyyumi AA; Finkel T
    Cancer Res; 1999 Dec; 59(23):5875-7. PubMed ID: 10606226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiostatin induces mitotic cell death of proliferating endothelial cells.
    Hari D; Beckett MA; Sukhatme VP; Dhanabal M; Nodzenski E; Lu H; Mauceri HJ; Kufe DW; Weichselbaum RR
    Mol Cell Biol Res Commun; 2000 May; 3(5):277-82. PubMed ID: 10964751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth.
    O'Reilly MS
    EXS; 1997; 79():273-94. PubMed ID: 9002223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiostatin(4.5)-mediated apoptosis of vascular endothelial cells.
    Hanford HA; Wong CA; Kassan H; Cundiff DL; Chandel N; Underwood S; Mitchell CA; Soff GA
    Cancer Res; 2003 Jul; 63(14):4275-80. PubMed ID: 12874037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene.
    Ishikawa H; Nakao K; Matsumoto K; Ichikawa T; Hamasaki K; Nakata K; Eguchi K
    Hepatology; 2003 Mar; 37(3):696-704. PubMed ID: 12601367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer.
    Sim BK; O'Reilly MS; Liang H; Fortier AH; He W; Madsen JW; Lapcevich R; Nacy CA
    Cancer Res; 1997 Apr; 57(7):1329-34. PubMed ID: 9102221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of tumor growth with recombinant murine angiostatin.
    Wu Z; O'Reilly MS; Folkman J; Shing Y
    Biochem Biophys Res Commun; 1997 Jul; 236(3):651-4. PubMed ID: 9245707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiostatin inhibits extracellular HIV-Tat-induced inflammatory angiogenesis.
    Benelli R; Morini M; Brigati C; Noonan DM; Albini A
    Int J Oncol; 2003 Jan; 22(1):87-91. PubMed ID: 12469189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis.
    Pozzi A; LeVine WF; Gardner HA
    Oncogene; 2002 Jan; 21(2):272-81. PubMed ID: 11803470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiostatin binds ATP synthase on the surface of human endothelial cells.
    Moser TL; Stack MS; Asplin I; Enghild JJ; Højrup P; Everitt L; Hubchak S; Schnaper HW; Pizzo SV
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2811-6. PubMed ID: 10077593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis.
    Ji WR; Barrientos LG; Llinás M; Gray H; Villarreal X; DeFord ME; Castellino FJ; Kramer RA; Trail PA
    Biochem Biophys Res Commun; 1998 Jun; 247(2):414-9. PubMed ID: 9642142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiostatin-like molecules are generated by snake venom metalloproteinases.
    Ho PL; Serrano SM; Chudzinski-Tavassi AM; Moura da Silva AM; Mentele R; Caldas C; Oliva ML; Batista IF; Oliveira ML
    Biochem Biophys Res Commun; 2002 Jun; 294(4):879-85. PubMed ID: 12061789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel strategy for the tumor angiogenesis-targeted gene therapy: generation of angiostatin from endogenous plasminogen by protease gene transfer.
    Matsuda KM; Madoiwa S; Hasumi Y; Kanazawa T; Saga Y; Kume A; Mano H; Ozawa K; Matsuda M
    Cancer Gene Ther; 2000 Apr; 7(4):589-96. PubMed ID: 10811477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined effects of angiostatin and ionizing radiation in antitumour therapy.
    Mauceri HJ; Hanna NN; Beckett MA; Gorski DH; Staba MJ; Stellato KA; Bigelow K; Heimann R; Gately S; Dhanabal M; Soff GA; Sukhatme VP; Kufe DW; Weichselbaum RR
    Nature; 1998 Jul; 394(6690):287-91. PubMed ID: 9685160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p21Cip1 levels differentially regulate turnover of mature endothelial cells, endothelial progenitor cells, and in vivo neovascularization.
    Brühl T; Heeschen C; Aicher A; Jadidi AS; Haendeler J; Hoffmann J; Schneider MD; Zeiher AM; Dimmeler S; Rössig L
    Circ Res; 2004 Mar; 94(5):686-92. PubMed ID: 14752032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2.
    Oh HK; Ha JM; O E; Lee BH; Lee SK; Shim BS; Hong YK; Joe YA
    Cancer Res; 2007 May; 67(10):4851-9. PubMed ID: 17510415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3.
    MacDonald NJ; Murad AC; Fogler WE; Lu Y; Sim BK
    Biochem Biophys Res Commun; 1999 Oct; 264(2):469-77. PubMed ID: 10529387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kringle 5 causes cell cycle arrest and apoptosis of endothelial cells.
    Lu H; Dhanabal M; Volk R; Waterman MJ; Ramchandran R; Knebelmann B; Segal M; Sukhatme VP
    Biochem Biophys Res Commun; 1999 May; 258(3):668-73. PubMed ID: 10329443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiostatin upregulates E-selectin in proliferating endothelial cells.
    Luo J; Lin J; Paranya G; Bischoff J
    Biochem Biophys Res Commun; 1998 Apr; 245(3):906-11. PubMed ID: 9588213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple forms of angiostatin induce apoptosis in endothelial cells.
    Lucas R; Holmgren L; Garcia I; Jimenez B; Mandriota SJ; Borlat F; Sim BK; Wu Z; Grau GE; Shing Y; Soff GA; Bouck N; Pepper MS
    Blood; 1998 Dec; 92(12):4730-41. PubMed ID: 9845539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.